▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Please report any adverse events via your national reporting system. Adverse events can also be reported to Alexion Pharmaceuticals by contacting: https://contactazmedical.astrazeneca.com.
Please refer to the Summary of Product Characteristics for further information.
healthcare professional
The maximum recommended dose of STRENSIQ® is 6 mg/kg of body weight per week as either:1
The maximum volume of medicinal product per injection should not exceed 1 ml. If more than 1 ml is required, multiple injections may be administered at the same time.1
STRENSIQ® should be administered using sterile disposable syringes and injection needles. The syringes should be of small enough volume that the prescribed dose can be withdrawn from the vial with reasonable accuracy.1
Injection sites should be rotated and carefully monitored for signs of potential reactions.1
Injections can be self-administered at home or by a carer. Patients can only self-inject if they have been properly trained on administration procedures. For handling of the medicinal product before administration, please refer to section 6.6 of the SmPC.1
STRENSIQ® should be administered using sterile disposable syringes and injection needles. The syringes should be of small enough volume that the prescribed dose can be withdrawn from the vial with reasonable accuracy.1
Injection sites should be rotated and carefully monitored for signs of potential reactions.1
Injections can be self-administered at home or by a carer. Patients can only self-inject if they have been properly trained on administration procedures. For handling of the medicinal product before administration, please refer to section 6.6 of the SmPC.1
Please refer to the dosing chart available in the STRENSIQ® Summary of Product Characteristics. The calculator below may help with calculating the necessary STRENSIQ® dosing values.1
Drag the button across the slider bar to select your patient's body weight (kg). The body weight variable will automatically snap to the nearest recognised figure in line with the STRENSIQ® weight-based dosing.
Drag the button across the slider bar to select your patient's body weight (kg). The body weight variable will automatically snap to the nearest recognised figure in line with the STRENSIQ® weight-based dosing.
For optimal dosing, patient weight should be checked regularly. STRENSIQ® is for subcutaneous use only. It is not intended for intravenous or intramuscular injection.1
For more information on the dosing and administration schedule of STRENSIQ®, please see the Summary of Product Characteristics.1
HPP, hypophosphatasia.
This medicinal product has been authorised under ‘exceptional circumstances’. This means that due to the rarity of the disease it has not been possible to obtain complete information on this medicinal product.
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Please report any adverse events via your national reporting system. Adverse events can also be reported to Alexion Pharmaceuticals by the following link: https://contactazmedical.astrazeneca.com/
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Please report any adverse events via your national reporting system. Adverse events can also be reported to Alexion Pharmaceuticals by the following link: https://contactazmedical.astrazeneca.com/